Casper Sleep
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Casper Sleep was the post-IPO, then private, phase of the DTC mattress brand Casper. After the disastrous 2020 IPO and the 2021 take-private by Durational Capital (about $308 million, a quarter of the debut price), the company operated as a shrinking shadow of its startup self: the once-vaunted R&D lab went silent after June 2021, the ambition to be the 'Nike of sleep' was abandoned, and CEO Emilie Arel redefined it bluntly as 'a mattress retailer.' It sold its Canadian assets to Sleep Country for $20.6 million in 2023 — Sleep Country also took a $4.5 million marketing transition fee, three-year warrants convertible into a 1% stake, and $20 million in convertible notes convertible into about 5% of Casper's shares — and faded into a wholesale/retail brand far from its former glory.
02 / Casper Sleep FAILURE REASONS
Failure reasons
The private-era decline extended the IPO-era causes. First, the business never found a path to profitability: even after going private, the brand remained unprofitable and dependent on the new owner's forbearance. Second, the differentiation was gone — the R&D engine that once justified premium positioning stopped publishing and innovating, while mattress retail commoditized. Third, asset sales signaled retreat: selling the entire Canadian business (72 brick-and-mortar outlets, six in Canada, plus e-commerce) to Sleep Country for $20.6 million showed the company liquidating geographies rather than growing them. Fourth, strategic drift: the pivot from lifestyle brand to 'mattress retailer' conceded the original vision; as The Street put it, 'Casper as a company disappears, a ghost of its former self,' with Sleep Country positioned as the logical eventual buyer once Durational exits.
03 / EVENT HISTORY
Events in the structured record
- Disastrous IPO
Went public in February at $13/share (~$575M valuation) after a $1.1B private mark; net loss nearly $90M on $497M revenue.
- Taken private
Durational Capital agreed in November 2021 to buy Casper for ~$308M ($6.90/share); deal closed in Q1 2022.
- Strategic retreat
R&D lab went silent; management repositioned the company as 'a mattress retailer' rather than the 'Nike of sleep.'
- Canadian exit
Sold all Canadian assets to Sleep Country for $20.6M plus warrants, notes and a marketing transition fee; the brand faded to a wholesale/retail label.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Q1 2022: Durational Capital's take-private of Casper closed; the company left the public market worth roughly a quarter of its February 2020 IPO price and began operating as a private portfolio company.
- 02
2021–2022: the once-vaunted Casper R&D lab stopped posting to its blog after June 2021; new management dropped the 'Nike of sleep' lifestyle-brand ambition, with CEO Emilie Arel declaring, 'We're not in the business of not making money anymore.'
- 03
2023: Casper sold 100% of its Canadian assets — including six stores — to Sleep Country for $20.6 million, plus a $4.5 million marketing transition fee, three-year warrants convertible into a 1% stake, and $20 million of convertible notes convertible into about 5% of Casper's shares.
- 04
Ongoing: the brand survived only as a retail/wholesale mattress label distributed through partners including Sleep Country, a 'ghost of its former self' while Sleep Country emerged as the logical eventual buyer once Durational exits.